The latest development in very promising diet pills seems to be coming from the Genaera Corporation, which has recently announced that it is beginning the release of its data from the preclinical trials on trodusquemine (MSI-1436). This drug is currently being considered to be an incredible new treatment for both obesity and type 2 diabetes.